CROSS COUNTRY HEALTHCARE INC
A North American skilled nursing provider offering post-acute care and rehabilitation services to help patients recover from surgery and injury.
A North American skilled nursing provider offering post-acute care and rehabilitation services to help patients recover from surgery and injury.
Despite recent financial headwinds, the company maintains a robust cash position of $81.6M and generated strong operating cash flow of $120.1M, providing liquidity for potential strategic pivots. The extensive facility network and diversified service offerings could allow the company to weather regulatory storms and regain market share if management executes a turnaround strategy effectively. A successful restructuring could unlock significant value from its substantial gross profit base of $1.34B.
The trajectory of declining revenue and net losses signals a fundamental business model crisis that may not be easily reversible without major external intervention. The company has depleted retained earnings by over $200M and is aggressively buying back shares despite poor profitability, which could deplete capital reserves further. Investors should avoid the stock until there is clear evidence of stabilizing revenue growth and a return to consistent net income generation.
Cross Country Healthcare Inc operates as a skilled nursing provider serving communities across North America, delivering post-acute care and rehabilitation services through a network of facilities. The company focuses on helping patients recover from surgery, injury, or illness by providing comprehensive medical and supportive care in both short-term and long-term settings.
The company faces a severe financial downturn characterized by a dramatic 53% revenue contraction over three years and a shift from profitability to a $14.6M net loss in the most recent period. While cash flow from operations remained positive at $120.1M, this was insufficient to cover financing outflows of $46.8M and share repurchases of $37.3M, resulting in a significant reduction in shareholder equity. The large non-cash adjustments of $290.9M suggest aggressive accounting or complex restructuring activities that obscure underlying operational performance.
The post-acute care industry is undergoing significant transformation driven by aging demographics, regulatory reforms, and shifting reimbursement models from fee-for-service to value-based care. Competition is intensifying as consolidation increases among large providers while smaller operators face margin compression from rising operational costs. Regulatory scrutiny on skilled nursing facilities has tightened, forcing companies to adapt quickly or risk losing market access.
| Metric | 2022 | 2023 | 2024 |
|---|---|---|---|
| Revenue | $2.81B | $2.02B | $1.34B |
| Cost of Revenue | $0 | $0 | $0 |
| Gross Profit | $2.81B | $2.02B | $1.34B |
| Operating Expenses | $2.53B | $1.91B | $1.36B |
| Operating Income | $273.1M | $112.7M | $-16.9M |
| G&A | $324.2M | $300.4M | $233.4M |
| Stock-Based Comp | $7.4M | $6.6M | $6.0M |
| D&A | $12.6M | $18.3M | $18.2M |
| Other OpEx | $2.21B | $1.61B | $1.13B |
| Non-Operating Income | $-16.8M | $-9.8M | $467.0K |
| Interest Expense | $14.4M | $8.1M | — |
| Interest Income | — | — | $2.0M |
| Pre-Tax Income | $256.3M | $102.9M | $-16.4M |
| Income Tax | $67.9M | $30.3M | $-1.8M |
| Continuing Ops | $188.5M | $72.6M | $-14.6M |
| Discontinued Ops | $0 | $0 | $0 |
| Net Income | $188.5M | $72.6M | $-14.6M |
| Minority Interest | $0 | $0 | $0 |
| Net to Common | $188.5M | $72.6M | $-14.6M |
| Metric | 2022 | 2023 | 2024 |
|---|---|---|---|
| Current Assets | $675.7M | $415.2M | $335.0M |
| Cash & Equivalents | $3.6M | $17.1M | $81.6M |
| Accounts Receivable | $641.6M | $372.4M | $223.2M |
| Other Current Assets | $30.5M | $25.7M | $30.1M |
| Long-Term Assets | $272.2M | $264.2M | $254.3M |
| PP&E (Net) | $19.7M | $27.3M | $28.9M |
| Intangibles | $44.7M | $54.5M | $42.2M |
| Goodwill | $163.3M | $135.4M | $135.1M |
| Operating Leases | $3.3M | $2.6M | $2.5M |
| Other LT Assets | $41.3M | $44.3M | $45.7M |
| Total Assets | $947.8M | $679.3M | $589.3M |
| Current Liabilities | $271.6M | $148.6M | $120.4M |
| Current Debt | $0 | — | — |
| Current Leases | $4.1M | $2.6M | $2.1M |
| Other Current Liab | $240.5M | $130.0M | $96.9M |
| Long-Term Liabilities | $219.0M | $57.3M | $49.9M |
| Long-Term Debt | $150.7M | — | — |
| LT Operating Leases | $4.9M | $2.7M | $1.8M |
| Other LT Liab | $63.4M | $54.7M | $48.1M |
| Total Liabilities | $490.6M | $205.9M | $170.3M |
| Shareholders' Equity | $457.2M | $473.4M | $419.0M |
| Retained Earnings | $165.7M | $238.4M | $218.1M |
| AOCI | $-1.4M | $-1.4M | $-1.4M |
| Total L&E | $947.8M | $679.3M | $589.3M |
| Metric | 2022 | 2023 | 2024 |
|---|---|---|---|
| Net Income (CFO) | $188.5M | $72.6M | $-14.6M |
| Non-Cash Adjustments | $-273.5M | $547.4M | $290.9M |
| Working Capital Changes | $219.1M | $-371.5M | $-156.3M |
| Cash from Operations | $134.1M | $248.5M | $120.1M |
| Capital Expenditures | $8.8M | $14.0M | $8.7M |
| Cash from Investing | $-43.9M | $-13.8M | $-8.7M |
| Share Buybacks | $35.3M | $57.7M | $37.3M |
| Cash from Financing | $-87.6M | $-221.2M | $-46.8M |
| FX Effect | $-9.0K | $8.0K | $-14.0K |
| Net Change in Cash | $2.6M | $13.5M | $64.5M |
| Beginning Cash | $1.0M | $3.6M | $17.1M |
| Ending Cash | $3.6M | $17.1M | $81.6M |
The company's revenue is primarily derived from private pay patients and third-party insurance providers, with a significant portion of gross profit generated by short-term acute rehabilitation services. Operations are structured around various facility types including skilled nursing facilities, intermediate care facilities, and continuing care facilities, serving diverse patient needs across different geographic markets.
Significant decline in revenue from $2.81B in 2022 to $1.34B in 2024 due to industry-wide regulatory pressures and reimbursement rate changes. Substantial net loss of $14.6M in the latest year alongside a retained earnings deficit of $218.1M indicating financial distress. High sensitivity to changes in government healthcare policies affecting Medicaid/Medicare reimbursements. Operational challenges related to staffing shortages and rising labor costs impacting margins.
Extensive national footprint providing operational stability and economies of scale in the post-acute care market. Strong relationships with private pay clients and insurance carriers ensuring steady referral flows. Established reputation for quality patient outcomes and comprehensive rehabilitation programs.
Not financial advice. All content is for informational purposes only. Data may contain errors. Consult a qualified financial advisor before making investment decisions.